Matches in Nanopublications for { ?s ?p "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951739.RACFwx1rxhA0pUbk3uBFzH2t7MRIMXwZ9JUSCozY4Si_E130_provenance.
- NP917753.RA5bzkqinNssWcxSGLWPKx8zq0OK5KNVG6p7xVHk_uGA0130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917753.RA5bzkqinNssWcxSGLWPKx8zq0OK5KNVG6p7xVHk_uGA0130_provenance.
- NP1137420.RA9zKoDQONNbPljB5etOPYM_5NOQnAgSwoyI1BNPT6v68130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137420.RA9zKoDQONNbPljB5etOPYM_5NOQnAgSwoyI1BNPT6v68130_provenance.
- NP1137423.RAZkuABkN56EIX4fKRTq9CHVZMM1oi4tHoVkSbqLZvATE130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137423.RAZkuABkN56EIX4fKRTq9CHVZMM1oi4tHoVkSbqLZvATE130_provenance.
- assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1137421.RAJ97LLPM-HBph1KQTxTTC-PBMWWTesxW3-6HCk5sH2ts130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137421.RAJ97LLPM-HBph1KQTxTTC-PBMWWTesxW3-6HCk5sH2ts130_provenance.
- NP1137422.RAI_VqLU6HUf9NjM6pu5qmpW7BVRrGEKvmtEcMtm-FNDU130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137422.RAI_VqLU6HUf9NjM6pu5qmpW7BVRrGEKvmtEcMtm-FNDU130_provenance.
- assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP917907.RAIJBsPu_BnSF134TxmQKM56NZK2Tud8lUqShuGW5Li7E130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917907.RAIJBsPu_BnSF134TxmQKM56NZK2Tud8lUqShuGW5Li7E130_provenance.
- NP951741.RAssJxJSZeBghQf9RzomZQYbN7z9bCiAd6pJzx7Jlv-nQ130_assertion description "[The results demonstrate that FAM83D has prognostic value for breast cancer patients and is a novel oncogene in breast cancer development that at least in part acts through mTOR hyper-activation by inhibiting FBXW7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951741.RAssJxJSZeBghQf9RzomZQYbN7z9bCiAd6pJzx7Jlv-nQ130_provenance.